The rise and fall of Theranos, in one graphic

Theranos, the blood-testing startup with a $9 billion valuation, has had a turbulent year.

On Wednesday, the company announced major changes, including that its president and chief operating officer Sunny Balwani, who served as CEO and founder Elizabeth Holmes' second-in-command, is retiring.

Here's a review of the events that led up to this point over the last year. Advertisement

BI_Graphic The rise and fall of Theranos (1)

Dragan Radovanovic/Business Insider

NOW WATCH: NASA is looking for ways to dispose of dead bodies in space - and it's getting weird